Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
9.40
-0.04 (-0.42%)
Feb 20, 2026, 4:00 PM EST - Market closed

Grifols Revenue

Grifols had revenue of 1.87B EUR in the quarter ending September 30, 2025, with 4.04% growth. This brings the company's revenue in the last twelve months to 7.52B, up 7.31% year-over-year. In the year 2024, Grifols had annual revenue of 7.21B with 9.41% growth.

Revenue (ttm)
7.52B EUR
Revenue Growth
+7.31%
P/S Ratio
0.91
Revenue / Employee
316,727 EUR
Employees
23,737
Market Cap
7.98B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20247.21B620.41M9.41%
Dec 31, 20236.59B528.01M8.71%
Dec 31, 20226.06B1.13B22.92%
Dec 31, 20214.93B-406.92M-7.62%
Dec 31, 20205.34B241.35M4.73%
Dec 31, 20195.10B611.97M13.64%
Dec 31, 20184.49B168.65M3.91%
Dec 31, 20174.32B268.24M6.62%
Dec 31, 20164.05B115.27M2.93%
Dec 31, 20153.93B579.18M17.26%
Dec 31, 20143.36B613.65M22.38%
Dec 31, 20132.74B120.79M4.61%
Dec 31, 20122.62B825.33M45.96%
Dec 31, 20111.80B804.88M81.24%
Dec 31, 2010990.73M77.54M8.49%
Dec 31, 2009913.19M98.88M12.14%
Dec 31, 2008814.31M111.02M15.79%
Dec 31, 2007703.29M54.87M8.46%
Dec 31, 2006648.42M124.69M23.81%
Dec 31, 2005523.73M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Merck & Co.65.01B
Pfizer62.58B
Sanofi54.85B
Novo Nordisk48.59B
Bristol-Myers Squibb Company48.19B
GSK plc43.97B
Amgen36.75B
Gilead Sciences29.44B
Revenue Rankings